Orexo AB
556500-0600ActiveDeveloping innovative medicines using proprietary drug delivery technology.
Biotechnology Companyorexo.com
Oversigt
- 50–99
- Medarbejdere
- 100–500mio SEK
- Omsætning
- 1994
- Grundlagt
Nøglebeslutningstagere
Nikolaj Sørensen
CEO
@orexo.com
Robert DeLuca
President of Orexo US Inc.
@orexo.com
Robert Rönn
SVP & Head of R&D
@orexo.com
Robert A. DeLuca
President Orexo US Inc.
@orexo.com
+7 flere kontakter i Funnelfeedr
Beskrivelse
Orexo is a Swedish biotechnology company focused on advancing treatments for severe diseases and developing life-saving rescue medications. The core of their innovation lies in their proprietary AmorphOX ® drug delivery technology. This technology significantly improves the bioavailability and stabi...
INSTITUT PRODUITS SYNTHESE (IPSEN) AB